
Álex Pérez Sánchez was born in Rubí in 1999. He is currently a PhD student at MolBioMed. He studied Chemistry at the Universitat Autònoma de Barcelona during the years 2017-2021 and, subsequently, the Erasmus Mundus Master in Theoretical Chemistry and Computational Modelling during the years 2021-2023, at the University of Barcelona. Durant els estudis de grau va poder estar durant 6 mesos a la Uppsala Universitet d’Erasmus, i durant el segon any de màster ha pogut fer estades a la Università degli Studi di Perugia i la Università degli studi di Trieste.
He is currently working on his doctoral thesis entitled: “Design through biomolecular simulations of drugs for inflammatory-based diseases”. His research focuses on the study of cyclooxygenases, a type of enzyme involved in the inflammatory response, and inflammation receptors.
Latest publications


J. Am. Chem. Soc. · 2026
Photoswitchable COX-2-Selective Inhibitors as Light-Regulated Anti-Inflammatory Agents


Protein Science · 2026
Omega-3 DHA as a blank canvas: A molecular approximation to how lipid mediators modulate LGR6 in inflammation resolution


Protein Science · 2025
First-principles simulations of the fluorescence modulation of a COX-2-specific fluorogenic probe upon protein dimerization for cancer discrimination
Divulgació: El dímer de la COX-2 com a nova diana terapèutica contra el càncer (UAB Divulga, 2025). Llista completa a ORCID.